newsfilter
← Latest News
GlobeNewswire·

AC Immune Third Quarter 2026 Financial and Corporate Update

AC Immune Third Quarter 2026 Financial and Corporate Update Positive clinical and regulatory progress achieved across wholly-owned pipeline ACI-7104 received FDA Fast Track designation, Investigational New Drug (IND)